PFA-100 System
The PFA-100® System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.
The PFA-100 System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.
- Helps detect inherited, acquired and drug-induced platelet dysfunction
- Screening test for patients with impaired primary hemostasis, such as von Willebrand disease1
- Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients2
- Assesses the platelet dysfunction due to the effect of Aspirin
- Evaluates platelet dysfunction in children over 1 year of age3
- Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
